Europe and Australia that evaluated its efficacy as adjunctive therapy in adult patients with partial-onset seizures (according to the 1981 International Classification of Epileptic Seizures ...

So far, LCM has only been evaluated as adjunctive therapy in adult patients with partial-onset seizures and its use should be restricted to that patient population until further clinical data are ...

The World Health Organisation (WHO) says that around 50 million people across the world suffer from epilepsy which makes it one of the most common neurological diseases. Read on as an expert shares ...